These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 17395730

  • 1. Vaccines against Francisella tularensis.
    Wayne Conlan J, Oyston PC.
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [Abstract] [Full Text] [Related]

  • 2. Vaccination strategies for Francisella tularensis.
    Isherwood KE, Titball RW, Davies DH, Felgner PL, Morrow WJ.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1403-14. PubMed ID: 15919131
    [Abstract] [Full Text] [Related]

  • 3. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P, Twine S, Shen H, Harris G, Chen W, Sjostedt A, Conlan W.
    Mol Immunol; 2013 May 17; 54(1):58-67. PubMed ID: 23201853
    [Abstract] [Full Text] [Related]

  • 4. Francisella tularensis vaccines.
    Griffin KF, Oyston PC, Titball RW.
    FEMS Immunol Med Microbiol; 2007 Apr 17; 49(3):315-23. PubMed ID: 17316369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW.
    Future Microbiol; 2011 Apr 17; 6(4):391-405. PubMed ID: 21526941
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M, Choules G, Rogers D, Titball RW.
    Vaccine; 2005 Apr 08; 23(20):2680-6. PubMed ID: 15780452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nature of protective immunity to Francisella tularensis.
    Tärnvik A.
    Rev Infect Dis; 1989 Apr 08; 11(3):440-51. PubMed ID: 2665002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H, Chen W, Conlan JW.
    Microb Pathog; 2004 Aug 08; 37(2):107-10. PubMed ID: 15312850
    [Abstract] [Full Text] [Related]

  • 15. Biosafety and selectable markers.
    Titball RW, Sjostedt A, Pavelka MS, Nano FE.
    Ann N Y Acad Sci; 2007 Jun 08; 1105():405-17. PubMed ID: 17416926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The tularaemia vaccine.
    Sandström G.
    J Chem Technol Biotechnol; 1994 Apr 08; 59(4):315-20. PubMed ID: 7764815
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative proteome analysis of fractions enriched for membrane-associated proteins from Francisella tularensis subsp. tularensis and F. tularensis subsp. holarctica strains.
    Pavkova I, Reichelova M, Larsson P, Hubalek M, Vackova J, Forsberg A, Stulik J.
    J Proteome Res; 2006 Nov 08; 5(11):3125-34. PubMed ID: 17081064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.